Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
trial enrollment
Biotech
Regeneron seeks clarity on confirmatory trials after FDA hurdle
Regeneron's Andres Sirulnik says blood cancer medicine odronextamab enrollment is going fine, days after FDA rejection.
Annalee Armstrong
Mar 29, 2024 5:00am
NCI launches remote staff pilot to boost trial enrollment
Mar 5, 2024 4:00pm
Medidata extends Thermo Fisher PPD deal, including AI product
Feb 28, 2024 3:10pm
Palatin plans phase 3 tweaks after dry eye study misses primary
Feb 28, 2024 10:25am
Trialbee, Massive Bio link to match cancer patients with trials
Feb 1, 2024 10:00am
BMS taps Arch-backed startup to change cancer trial Paradigm
Oct 6, 2023 10:05am